Latin America Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in Latin America is expected to reach a projected revenue of US$ 96.2 million by 2030. A compound annual growth rate of 7.8% is expected of Latin America sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$52.7
Forecast, 2030 (US$M)
$96.2
CAGR, 2023 - 2030
7.8%
Report Coverage
Latin America

Latin America sepsis diagnostics market, 2018-2030 (US$M)

Latin

Latin America sepsis diagnostics market highlights

  • The Latin America sepsis diagnostics market generated a revenue of USD 52.7 million in 2022.
  • The market is expected to grow at a CAGR of 7.8% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2023 to 2030.


Latin America data book summary

Market revenue in 2022USD 52.7 million
Market revenue in 2030USD 96.2 million
Growth rate7.8% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Latin America region accounted for 5.3% of the global sepsis diagnostics market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 431.0 million by 2030.

Blood culture media was the largest segment with a revenue share of 38.9% in 2022. Horizon Databook has segmented the Latin America sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


Sepsis represents a significant public health challenge in Latin America, characterized by a high incidence rate and substantial associated mortality. Early and accurate diagnosis of sepsis is crucial for initiating timely and appropriate treatment, which can prevent patient deterioration & enhance overall outcome. There is a growing focus on improving sepsis diagnosis within the region, driven by efforts to develop and implement innovative diagnostic tools.

In Latin America, where several countries face economic constraints, there is a pressing need for cost-effective diagnostic & treatment solutions. The region's diverse economic landscape includes low-income countries requiring affordable healthcare interventions and more developed nations with better access to advanced medical technologies.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Latin America sepsis diagnostics market size, by country, 2018-2030 (US$M)

Latin America Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Latin America sepsis diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more